Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398456 · ClinicalTrials.gov registry record · NA
Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
A NA study, sponsored by Baylor Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 5,500
- Enrollment target
NCT07398456 is a NA study that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 5,500 participants.
The verdict
NCT07398456, a NA study, has not yet begun recruiting, sponsored by Baylor Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 5,500 participants
- Enrollment target
Study Summary
The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval. Additional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.
Interventions
- OTHER Educational Information via Smartphone App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,500 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07398456
The ClinicalTrials.gov registry entry for NCT07398456 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 5,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational Information via Smartphone App is the first listed.
NCT07398456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07398456 about?
NCT07398456 is a clinical study titled "Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas". The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval. Additio...
What is the current status of trial NCT07398456?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 5,500 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07398456?
The interventions under investigation include: Educational Information via Smartphone App (OTHER).
Who is sponsoring clinical trial NCT07398456?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.